» Articles » PMID: 12581551

Validation of the Short Form of the Spanish Hypertension Quality of Life Questionnaire (MINICHAL)

Overview
Journal Clin Ther
Specialty Pharmacology
Date 2003 Feb 13
PMID 12581551
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The finding that low health-related quality of life (HRQoL) can be a risk factor for future cardiovascular events in patients with hypertension emphasizes the need for disease-specific HRQoL assessment tools in this population.

Objective: This study evaluated the feasibility and psychometric properties of the short form of the Spanish Hypertension Quality of Life Questionnaire (MINICHAL).

Methods: An observational, prospective, multicenter study was carried out among patients with hypertension, stratified by sex and disease stage. The feasibility and validity of the MINICHAL were evaluated at baseline. Two follow-up visits were conducted at 1 and 6 months after the initial visit, during which the test-retest reliability and responsiveness to change of the MINICHAL were assessed, respectively.

Results: A total of 736 consecutive patients with hypertension were included. Mean (SD) administration time for the MINICHAL was 7.2 (6.5) minutes. In the validation process, factor analysis showed 2 dimensions: "State of mind" (StM) and "Somatic manifestations" (SM). The response level was high, with 94.3% of patients answering all items. Patients with a higher disease stage (ie, stage II/III hypertension) had a worse HRQoL than those with a lower disease stage (P < 0.01). Internal consistency was 0.87 for StM and 0.75 for SM. Test-retest reliability was 0.82 and 0.75 for the StM and SM dimensions, respectively. Among patients who reported experiencing a positive change in their overall health status 6 months after treatment initiation or treatment change, responsiveness to change ranged from 0.52 (better) to 1.14 (much better).

Conclusions: The MINICHAL questionnaire could be administered in a short time with a high response level and was found to have acceptable psychometric properties. The MINICHAL is a potentially useful tool for the evaluation of HRQoL among patients with hypertension in the routine clinical setting.

Citing Articles

Developing and testing culturally relevant bolt-on items for EQ-5D-5L in Chinese populations: a mixed-methods study protocol.

Mao Z, Fan J, Rencz F, Yang Z, Luo N, Wang P BMJ Open. 2024; 14(1):e081140.

PMID: 38286698 PMC: 10826542. DOI: 10.1136/bmjopen-2023-081140.


Development and validation of a disease-specific quality of life measure QLICD-HY (V2.0) for patients with hypertension.

Liu Y, Chang Y, Wan D, Li W, Xu C, Wan C Sci Rep. 2023; 13(1):12935.

PMID: 37558743 PMC: 10412614. DOI: 10.1038/s41598-023-39802-2.


Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia).

Costa S, Guerreiro J, Teixeira I, Helling D, Pereira J, Mateus C Front Pharmacol. 2022; 13:903270.

PMID: 36160402 PMC: 9493118. DOI: 10.3389/fphar.2022.903270.


Cross-cultural adaptation of the Spanish MINICHAL instrument into English for use in the United Kingdom.

Jordan A, Anning C, Wilkes L, Ball C, Pamphilon N, Clark C Health Qual Life Outcomes. 2022; 20(1):39.

PMID: 35246164 PMC: 8895672. DOI: 10.1186/s12955-022-01943-9.


Effectiveness of nursing case management versus usual care for blood pressure control in adults with hypertension: a systematic review.

Mantovanil M, Kalinke L, Silva A, Perez Arthur J, Radovanovic C, Bortolato-Major C Invest Educ Enferm. 2021; 39(1).

PMID: 33687808 PMC: 7987286. DOI: 10.17533/udea.iee.v39n1e04.